[HTML][HTML] Efficacy and safety of sirolimus in the treatment of vascular anomalies: a systematic review

C Freixo, V Ferreira, J Martins, R Almeida… - Journal of vascular …, 2020 - Elsevier
Objective The management of vascular anomalies is complex and requires a
multidisciplinary team with a combination of medical, surgical, and intervention treatments …

Epithelioid vascular tumors: a review

W Shon, SD Billings - Advances in anatomic pathology, 2019 - journals.lww.com
Vascular tumors are a diagnostically challenging area. This is particularly true in the case of
epithelioid vascular tumors. Not only is the distinction between different epithelioid vascular …

Expanding the spectrum of genetic alterations in pseudomyogenic hemangioendothelioma with recurrent novel ACTB-FOSB gene fusions

NP Agaram, L Zhang, P Cotzia… - The American journal of …, 2018 - journals.lww.com
Pseudomyogenic hemangioendothelioma (PHE) is an uncommon, rarely metastasizing
vascular neoplasm with predilection to affect young adults. The tumors often present as …

Telatinib is an effective targeted therapy for pseudomyogenic hemangioendothelioma

DGP Van IJzendoorn, S Sleijfer, H Gelderblom… - Clinical Cancer …, 2018 - AACR
Purpose: Pseudomyogenic hemangioendothelioma (PHE) is an extremely rare locally
aggressive neoplasm with endothelial differentiation, which often presents with multiple …

Pseudomyogenic hemangioendothelioma of skin, bone and soft tissue—a clinicopathological, immunohistochemical, and fluorescence in situ hybridization study

D Pradhan, K Schoedel, RL McGough, S Ranganathan… - Human Pathology, 2018 - Elsevier
Pseudomyogenic hemangioendothelioma (PHE) is an uncommon neoplasm with propensity
for local recurrence. The tumor mimics epithelioid hemangioendothelioma and epithelioid …

Clinicopathological study of pseudomyogenic hemangioendothelioma

N Yang, Y Huang, P Yang, W Yan, S Zhang, N Li… - Diagnostic …, 2023 - Springer
Objectives Pseudomyogenic hemangioendothelioma (PHE) is a rare intermediate
hemangioendothelioma. This article aims to study the clinicopathological features of PHE …

Pseudomyogenic hemangioendothelioma

A Al-Qaderi, AT Mansour - Archives of Pathology & …, 2019 - meridian.allenpress.com
First described in 2003 as epithelioid-sarcoma-like hemangioendothelioma and later in
2011 as pseudomyogenic hemangioendothelioma, this rare vascular tumor is of …

Gene fusions in vascular tumors and their underlying molecular mechanisms

SLM Ong, K Szuhai, JVMG Bovée - Expert review of molecular …, 2021 - Taylor & Francis
Introduction The group of vascular tumors contains many different entities, and is considered
difficult by pathologists, as they often have overlapping histological characteristics …

[HTML][HTML] Vascular tumor recapitulated in endothelial cells from hiPSCs engineered to express the SERPINE1-FOSB translocation

DGP van IJzendoorn, DCF Salvatori, X Cao… - Cell Reports …, 2020 - cell.com
Chromosomal translocations are prevalent among soft tissue tumors, including those of the
vasculature such as pseudomyogenic hemangioendothelioma (PHE). PHE shows …

[HTML][HTML] Primary vascular tumors of bone: a comprehensive literature review on classification, diagnosis and treatment

I Tortorelli, E Bellan, B Chiusole, F Murtas… - Critical Reviews in …, 2024 - Elsevier
Primary vascular tumors of bone are a heterogeneous group of neoplasms, ranging from
benign hemangiomas to frankly malignant epithelioid hemangioendotheliomas and …